Bull. A reverse split does not kill any company. Having no earnings/revenues kills a company. A reverse split while also generating real revenues and profits would be fine for the co. and the stock. So far this stock is nothing but a trading vehicle it certainly has not been an investment.
$1 would meen a $450mil mkt cap and growing. CC showed improvement but financials are terrible. They need sales of at least $50mil to justify current pricing and that would be with a pretty high net operating profit(which there is no proof of).
half of market cap traded today. What is the float? This is a standard Wall Street liquidity run up and will drop when volume drops and/or they release shares to increase float. Have fun til then.
Wow, can not believe this gets this valuation. Put it on my list of stocks to short in the future. Maybe will start at $55-60, should be there in a few days at this rate. Single digits once bubble bursts. JMHO
I think this is a pretty safe purchase down here. I also think it could go lower if biotech sells off again(it should) or the whole market corrects. Consider lower buy points a bargain(IMO). This could push near $100 if things go well, the main problem is that the company is a binary bet on drug approval or not(at least in the near term).
I have been trading in and out of this for several months. I have to say this has been trading very well in the past couple of weeks. Makes me believe that there could be some positives coming in subsequent months. At this mkt cap, fundamental improvement(I mean actually having fundamentals) could really send the PPS up. Time will tell...
I think the max is $125k. No big deal, but phase II or beyond would be real money for a company with none, and could be good PR and validation of technology. Could be good cash flow in a year if they get that far. Better to have sales ASAP.
Whether there is any substance or not, this stock is going to move higher in the short term til there is news. Volume is nuts. This may also mean that where there is smoke there is fire, but we will tell on the next news article. That will determine if there is a sustainable move or just more hype. JMHO
I listened to the CC last night. I actually think this company is going to be able to begin material sales in the near term. Their new head of sales has tons of contacts and industry experience. This appears to provide immediate opportunities for him to create sales, it also may offer the potential for cross marketing with MIM sales people that currently can not fill certain needs. Compared with the last CC this had many more items defined for actually moving a biz plan forward.
The negative, the company is burning shares to pull this off. Additionally the mkt cap is really high unless the company can create substantial sales in the near term($10mil plus). I hold a really small position, but would not be an aggressive buyer unless the price comes down a bunch. if it did this penny stock could actually make a go of it. JMHO
I think this stock should be bought now and on any weakness. The stock has dramatically underperformed WRLD even though that company is being investigated by the government and RM is not(yet). They do have some credit issues, but they appear very well priced in. Though anything can happen in the near term, I suspect there is big value at this price and that this will recover substantially above this price over the next few years.
Seems as if the determination will be a binary event in the near term. Stock up a ton or stock down. I expect to buy if it dips. I will also purchase a small amount now in case it pops. No huge positions, but I am still expecting that there technology will offer value well above current market price over the next few years. JMHO